Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05196113 · ClinicalTrials.gov registry record · NA

sipIT2: Improving Adherence to Fluid Intake Guidelines for Kidney Stone Prevention

A NA study, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
216
Enrollment target

NCT05196113: Completed NA study, sponsored by University of Michigan.

NCT05196113 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 216 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05196113, a NA study, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
216 participants
Enrollment target

Study Summary

The purpose of this study is to examine the feasibility of using sipIT tools (i.e., wrist-worn sensors, smart water bottles, mobile applications) to increase compliance with physician-recommended fluid consumption guidelines in participants with a history of urolithiasis.

Primary Outcome

Change in urine volume from baseline

Interventions

  • BEHAVIORAL sipIT

Trial Details

FieldValue
Enrollment Target 216 participants
Start Date 2022-01-04
Est. Completion 2025-04-28
Phase NA
University of Michigan

1,327 total trials

What the finished NCT05196113 record still lists

NCT05196113 is an interventional study that assigns participants to a tested intervention. The registered 216 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).

The record links to 0 conditions, and to 1 intervention - of which sipIT is the first listed.

NCT05196113 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05196113 about?

NCT05196113 is a clinical study titled "sipIT2: Improving Adherence to Fluid Intake Guidelines for Kidney Stone Prevention". The purpose of this study is to examine the feasibility of using sipIT tools (i.e., wrist-worn sensors, smart water bottles, mobile applications) to increase compliance with physician-recommended fluid consumption guidelines in participants with a history of urolithiasis.

What is the current status of trial NCT05196113?

This trial is currently completed. It is a NA study. The enrollment target is 216 participants. The study started on 2022-01-04. Estimated completion is 2025-04-28.

What interventions are being tested in trial NCT05196113?

The interventions under investigation include: sipIT (BEHAVIORAL).

Who is sponsoring clinical trial NCT05196113?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05196113's enrollment target sits among peer trials

216 485th of 2000 higher than 1,514 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02609685 · 216 participants · NA

    Active Surveillance of Papillary Thyroid Microcarcinoma

  • NCT04994873 · 216 participants · NA

    Skills to Enhance Positivity in Suicidal Youth

  • NCT05264779 · 216 participants · NA

    The Periviable GOALS Decision Support Tool

  • NCT05434130 · 216 participants · Phase 2

    Modulating Exercise Dosage to Improve Concussion Recovery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05196113, the US trial registry maintained by the National Library of Medicine. NCT05196113 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.